Chromadex Corp Valuation
CDXCDelisted Stock | USD 7.87 0.07 0.88% |
At this time, the firm appears to be overvalued. Chromadex Corp shows a prevailing Real Value of $6.28 per share. The current price of the firm is $7.87. Our model approximates the value of Chromadex Corp from analyzing the firm fundamentals such as Current Valuation of 567.71 M, profit margin of 0.09 %, and Return On Equity of 0.23 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Chromadex Corp's price fluctuation is unstable at this time. Calculation of the real value of Chromadex Corp is based on 3 months time horizon. Increasing Chromadex Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Chromadex Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chromadex Stock. However, Chromadex Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 7.87 | Real 6.28 | Hype 7.87 | Naive 7.92 |
The real value of Chromadex Stock, also known as its intrinsic value, is the underlying worth of Chromadex Corp Company, which is reflected in its stock price. It is based on Chromadex Corp's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Chromadex Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Chromadex Corp helps investors to forecast how Chromadex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chromadex Corp more accurately as focusing exclusively on Chromadex Corp's fundamentals will not take into account other important factors: Chromadex Corp Total Value Analysis
Chromadex Corp is currently anticipated to have valuation of 567.71 M with market capitalization of 617.34 M, debt of 2.65 M, and cash on hands of 16.87 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Chromadex Corp fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
567.71 M | 617.34 M | 2.65 M | 16.87 M |
Chromadex Corp Investor Information
About 35.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Chromadex Corp had 1:3 split on the 13th of April 2016. Based on the analysis of Chromadex Corp's profitability, liquidity, and operating efficiency, Chromadex Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Chromadex Corp Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Chromadex Corp has an asset utilization ratio of 90.2 percent. This indicates that the Company is making $0.9 for each dollar of assets. An increasing asset utilization means that Chromadex Corp is more efficient with each dollar of assets it utilizes for everyday operations.Chromadex Corp Ownership Allocation
Chromadex Corp holds a total of 77.75 Million outstanding shares. Chromadex Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Chromadex Corp Profitability Analysis
The company reported the previous year's revenue of 61.59 M. Net Income was 8.55 M with profit before overhead, payroll, taxes, and interest of 61.59 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chromadex Corp's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chromadex Corp and how it compares across the competition.
About Chromadex Corp Valuation
The delisted stock valuation mechanism determines Chromadex Corp's current worth on a weekly basis. Our valuation model uses a comparative analysis of Chromadex Corp. We calculate exposure to Chromadex Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chromadex Corp's related companies.ChromaDex Corporation operates as a bioscience company focusing on healthy aging. ChromaDex Corporation is headquartered in Los Angeles, California. Chromadex Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 115 people.
Chromadex Corp Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 78.1 M | |
Forward Price Earnings | 65.3595 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Chromadex Stock
If you are still planning to invest in Chromadex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chromadex Corp's history and understand the potential risks before investing.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Commodity Directory Find actively traded commodities issued by global exchanges |